Medical Device Software: Complying with the MDR & FDA Regulations

An Introduction to Medical Device Software: Regulations & Requirements to include EU & FDA Guidance and Risk Management

20-21 Nov 2018

& 1-2 May 2019

GBP 1,499 1,299 *
EUR 2,099 1,819 *
USD 2,338 2,026 *
* When you book before 5 Oct

Book now

Course Overview

This course will provide a comprehensive introduction to the regulations and requirements that apply to medical device software wordwide. The seminar will be highly interactive, using real life examples and state-of-the-art practices. You will learn how to prepare compliant technical files and 510(k)s for medical device software products and get insight into state-of-the-art standards and FDA guidance applicable to software.

Day two of the course goes more in depth. It provides for a thorough understanding on the practical implementation of the standards and guidance applicable to software. Practical experience is shared and common pitfalls identified for establishing and maintaining compliant processes for design control, risk management, usability engineering, verification and validation
and clinical evaluations for software.

Why you should attend

BENEFITS OF ATTENDING:

  • Learn how to qualify and classify software in Europe and the rest of the world
  • Get in-depth understanding of the interpretations of MDR Classification Rule 10, 11, 12, 13, 15 and 22
  • Understand the implications of the MDR and US Code of Federal Regulations for software
  • Gain regulatory guidance on mobile apps, software as a service, cloud computing, artificial intelligence and continuous learning software
  • Learn how to write 510K and Technical Files
  • Get a practical understanding of quality management, design control and how it applies to agile software development
  • Hear the best practices on cyber security, risk management, usability and validation n Learn the principles of clinical evaluations for software as a medical device
  • Gain an insight into state-of-the-art standards applicable to software

Who should attend

  • Senior management and project leaders
  • Software product managers, researchers, developers and clinical experts
  • Software development process managers
  • IT managers and integrators
  • Internal and external auditors and/or consultants
  • Regulatory affairs professionals
  • Quality system and quality assurance personnel
  • Technical and medical writers
  • GUI designers

Programme at a glance...

Day One

Laws and regulations A software perspective

Introduction to the regulations

Medical device software qualification and classification

Software classification – EU

Software classification case studies – EU

Classification according to the FDA

Bringing medical device software on the EU market

Notified Bodies and the evidence they consider

Practical construction of a technical file

EUDAMED registration and distribution chain responsibilities

On the market

End of day one

Day two

Laws and regulations – A software perspective cont.

Bringing medical software on the US market

Rest of the World (Brazil, Canada etc.)

Standards and their implementation – A software perspective

Standards

Fundamental principles design control

Design activities in detail

End of course

Presenters

Peter Pringle

Peter Pringle is a consultant with international hospital experience; he has managed projects in installation, process and software. His medical software experience brings a unique understanding of the quality systems and configuration control that is required to make a project right first time.
He has the ability to focus and create a vision, interact and motivate at all levels while not afraid of confutation and accepting responsibilities. He enjoys the challenge of empowering people to be accountable for their tasks bringing about the ability to see the big picture in a very short space of time.
Since May 2000 he has operated as an independent (Accredited Business Link & MHRA) consultant. He has established an expertise in developing project proposals and stimulating co-maker and e-business relationships with many companies, also developing and submitting major project proposals for several clients with considerable success. From 1986 to 2000 he worked in the Radiotherapy division of Philips Medical Systems (purchased by Elekta of Sweden) whose main products consist of a range of computer controlled linear accelerators for the treatment of cancer.
He has worked extensively in Scandinavia, Germany, Italy, Russia, USA and Great Britain. With this experience he can bring a very personal view of project processes, interpretation and implementation to any forum, together with a unique ability to focus a team on the objectives and goals that are required by the sponsor of the project.
Peter is qualified in ISO 13485 / 9000 / 14000 / 14971 and prepares FDA pre audits, establishing technical documentation for product compliance to the Medical Device Directive, he also advises companies on software development procedures and documentation.

Koen Cobbaert

Koen Cobbaert is chair of COCIR’s software task force, COCIR is the European Trade Association representing the medical imaging, radiotherapy, health ICT and electromedical industries. In that role he co-authored the first and second edition of MEDDEV 2.1/6 on the qualification and classification of standalone software and is today co-authoring the software classification guidance for Rule 10 and 11 under the Medical Device Regulation. In that role Koen also co-authored the FAQ on 62304:2006. In his day to day job Koen works for Agfa Healthcare as regulatory affairs and quality assurance professional in the development of software applications for use in general radiology, nuclear medicine, cardiology and orthopaedics. He has submitted a variety of technical files and 510(k)s for software-only medical devices. He guards process compliance for solution development processes and is himself responsible for managing Agfa’s risk management, clinical evaluation and regulatory monitoring process. Koen has a master in electrical engineering and risk management.

Book now

20-21 Nov 2018
20-21 Nov 2018 Cavendish Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
GBP 1,299.00
EUR 1,819.00
USD 2,026.00
Until 5 Oct
Enrol now
1-2 May 2019
1-2 May 2019 Cavendish Hotel, London GBP 1,499.00
EUR 2,099.00
USD 2,338.00
+ VAT @ 20.00%
Enrol now

You may also be interested in

Previous customers include...

  • Biofortuna Ltd
  • Bristows LLP
  • Chiesi Farmaceutici S.p.a.
  • Cochlear Limited
  • Coloplast A/S
  • Covidien Deutschland GmbH
  • F. Hoffmann-La Roche AG
  • GSK
  • Hospira, a Pfizer Company
  • Inpeco SA
  • Medicines and Medical Devices Agency of Serbia
  • Mobidiag
  • Nemaura Pharma
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • Omron Healthcare
  • Omron Healthcare Europe BV
  • PA Consulting Group
  • Quanta Dialysis Technologies
  • Radiometer Medical ApS
  • Sagentia Limited
  • SGR Consulting Services Ltd
  • Technology Partnership Plc
  • Teva UK Limited
  • The Institute of Cancer Research
  • TomTom International B.V.
  • Toshiba Medical Visualization Systems
  • UCB
  • UCB BioPharma sprl
  • University of Cambridge

Good course. A lot of information in detail.

Jose Fernandez, Certification Manager, McLaren

A well structured, well presented programme

Peter Ogrodnik, Professor of Biomedical Engineering, Keele University

It was great that both speakers had an understanding of what devices IBA makes and they tried to give suitable answers for our case

Inez Wathion, Verification & Validation Officer, Ion Beam Applications SA

Excellent content - good choice of speakers

Malgorzata Wilinska, Research Associate, University of Cambridge

Very good presentation

Massimo Panonzini, , Inpeco SA

Very good

Robert Gay, Senior Regulatory Affairs Manager - External Products and Software, Cochlear Limited

Very good, I would recommend this course for beginners and advanced levels

Arnaud Biermann, Senior Manager Regulatory Affairs, Anteis SA

The presentations in the folders did not follow the order that was presented by the speakers. Always best to check beforehand with the speakers the order of information as ideally it should match of presentation. This meant we were all looking for the slides whilst the speakers had started, meaning we often missed some important points.

Priti Darjee, Associate Director Regulatory Affairs, UK, Teva UK Ltd